Healthcare - Biotechnology - NASDAQ - US
$ 7.93
-9.37 %
$ 842 M
Market Cap
-2.68
P/E
BALANCE SHEET
596 M
ASSETS
60 M
LIABILITIES
536 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
89bio, Inc.
| Current Assets | 594 M |
| Cash & Short-Term Investments | 579 M |
| Receivables | 0 |
| Other Current Assets | 14.7 M |
| Non-Current Assets | 2.74 M |
| Long-Term Investments | 0 |
| PP&E | 2.34 M |
| Other Non-Current Assets | 396 K |
| Current Liabilities | 29.6 M |
| Accounts Payable | 8.58 M |
| Short-Term Debt | 992 K |
| Other Current Liabilities | 20 M |
| Non-Current Liabilities | 30.4 M |
| Long-Term Debt | 26.6 M |
| Other Non-Current Liabilities | 3.74 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 316.2 | 55.3 | 150.7 | 204.7 | 93.4 | 11.2 |
| Short Term Investments | 262.7 | 132.9 | 98.3 | 106.4 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 14.7 | 15.8 | 11.3 | 5.6 | 2.0 | 82 K |
| Total Current Assets | 593.5 | 196.1 | 162.0 | 210.2 | 95.3 | 11.3 |
| PP&E | 2.3 | 0.5 | 0.1 | 0.2 | 0.2 | 33 K |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0.4 | 0.3 | 0.3 | 0.7 | 72 K | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 596.3 | 196.8 | 162.4 | 211.1 | 95.6 | 11.4 |
| LIABILITIES | ||||||
| Accounts Payable | 8.6 | 12.5 | 6.8 | 2.1 | 1.0 | 1.5 |
| Short Term Debt | 1.0 | 0.3 | 2.5 | 0 | 0 | 1.7 |
| Other Current Liabilities | 20.0 | 11.8 | 10.2 | 6.0 | 4.6 | 1.2 |
| Total Current Liabilities | 29.6 | 24.6 | 19.5 | 8.1 | 5.6 | 4.4 |
| Long Term Debt | 26.6 | 19.9 | 16.9 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 3.7 | 0.5 | 30 K | 0 | 0 | 0 |
| Total Liabilities | 60.0 | 45.0 | 36.5 | 8.1 | 5.6 | 27.4 |
| EQUITY | ||||||
| Common Stock | 93 K | 51 K | 20 K | 20 K | 14 K | 1 K |
| Retained Earnings | (457.4) | (315.2) | (213.2) | (123.1) | (73.6) | (16.2) |
| Other Accumulative Comprehensive Income/Loss | 0.2 | (0.3) | 64 K | 10 K | (95.6) | 6 K |
| Total Equity | 536.3 | 151.8 | 126.0 | 203.0 | 89.9 | (16.1) |
| Total Liabilities and Equity | 596.3 | 196.8 | 162.4 | 211.1 | 95.6 | 11.4 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 71.2 | 34.8 | 20.1 | 16.1 | 10.6 | 4.6 |